About Recursion

Recursion is a clinical stage TechBio company using artificial intelligence and automation to industrialise drug discovery. The Recursion Operating System integrates 65 petabytes of biological data from millions of weekly cell experiments to train machine learning models that identify drug targets and design optimised molecules for diseases with high unmet need. The platform addresses the 90% failure rate in traditional drug discovery by using cellular imaging and AI to map biological disruptions driving disease. Recursion has advanced a pipeline of first-in-class and best-in-class treatments for aggressive cancers and rare diseases, demonstrating improvements in speed, efficiency, and cost. Strategic partnerships with pharmaceutical and technology leaders accelerate new medicine discovery.